Install
Biotech
Biotechnology, gene editing, biopharma platforms, and clinical pipelines.
- 9 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
- Aerospace
- Agriculture
- Banking (Industry)
- Computing
- Consumer Goods
- Defense
- Energy & Utilities
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Real Estate (Commercial)
- Management & Consulting
- Manufacturing
- Technology
- Telecom
- Transportation & Logistics
- Automotive
- Construction
- Education & EdTech
- Hospitality & Travel
- Insurance (Industry)
- Mining & Materials
- Pharmaceuticals
Latest in Biotech
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
16+ min ago (124+ words) Your Privacy is Important to us Opt out of the sale or sharing of personal information Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics With the deal, Rona Therapeutics is set to receive an…...
Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics
10+ hour, 48+ min ago (128+ words) ZURICH, Oct 13 (Reuters) – Swiss drugmaker Roche entered a licensing agreement worth up to $1.16 billion with Rona Therapeutics for its investigational obesity drug candidate, the Chinese biotech firm said on Tuesday. Roche has been racing to break into the obesity drug…...
PathLabs Unifiers acquires remaining 30 pc stake in Centrapath Labs
3+ hour, 39+ min ago (167+ words) New Delhi, Oct 13 (PTI) Diagnostic services provider Dr Lal PathLabs Ltd on Tuesday said its subsidiary PathLabs Unifiers has acquired the remaining 30 per cent equity stake in Centrapath Labs. Following the acquisition at Rs 1,608.35 per share, CPL has become a…...
Richardson Electronics officer proposes $323K sale
1+ hour, 20+ min ago (242+ words) An officer proposes selling 15,432 Richardson Electronics (RELL) shares from stock awards. Stock Titan Richardson Electronics officer proposes $323K sale The notice traces the shares to stock awards dated July 21, 2020, and July 19, 2021. Sentiment and the balance of points Rhea-AI Sentiment reads the…...
‘Pharma Bro’ Martin Shkreli has caught the attention of federal and state authorities again
1+ hour, 36+ min ago (438+ words) “Pharma Bro” Martin Shkreli has caught the attention of federal and state authorities again. Since his 2022 release from prison for securities fraud, Shkreli — who gained national notoriety for inflating the price of a life-saving drug — has been livestreaming on YouTube…...
Dr Lal PathLabs acquires remaining 30% stake in Centrapath Labs
2+ hour, 37+ min ago (154+ words) The acquisition consolidates ownership of the Indore-based healthcare and diagnostic services provider under PathLabs Unifiers, a subsidiary of Dr Lal PathLabs Dr Lal PathLabs acquires remaining 30% stake in Centrapath Labs The acquisition consolidates ownership of the Indore-based healthcare and diagnostic…...
FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban
3+ hour, 59+ min ago (339+ words) The Federal Trade Commission and seven state attorneys general say that Martin Shkreli hasn't complied with his lifetime ban from the pharmaceutical industry. In a 37-page court filing, the FTC and the attorneys general state that Shkreli has repeatedly violated…...
TENX Stock Drifts Lower As Traders Watch Tight Range
2+ hour, 52+ min ago (381+ words) Tenax Therapeutics Inc. stocks have been trading down by -8.47 percent amid bearish sentiment over its latest clinical trial setback. TENX is a classic development-stage biotech: lots of runway, no profits yet. Tenax Therapeutics Inc. reported about $117.976M in cash and equivalents…...
Albert Raises $55M Series B to Scale the First Chemistry-Native AI
2+ hour, 54+ min ago (692+ words) OAKLAND, Calif., October 13, 2026--Albert, which has built the first chemistry-native AI operating system for R&D, today announced a $55 million Series B led by TCV with participation from new investors Delta-v Capital, Socium Ventures, HighSage Ventures, Coral Capital, and Legion…...
Nasdaq Stockholm Approves Humana Delisting
3+ hour, 24+ min ago (31+ words) www.marketscreener.com Published on 10/13/2026 at 09:49 am EDT Ambea AB continues to beat analysts' expectations August 07, 2025 at 05:26 am EDT...